Search results

Showing results for

The Jenner Institute is based within the Nuffield Department of Medicine, University of Oxford, and operates out of the Old Road Campus Research Building, in Headington, Oxford.

Publications

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains

Ulaszewska M. et al, (2026), Vaccines, 14, 273 - 273

Development and Evaluation of Compact Semi-Synthetic Promoters for Enhanced Antigen Expression in Adenoviral-Vectored Vaccines

Hlaváč M. et al, (2026), Vaccines, 14, 260 - 260

Large-scale distribution of cestode infections in wild gentoo penguins and their impact on the host microbiome

Kaczvinsky C. et al, (2026), Scientific Reports, 16

Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020–2025): Clinical Features and Wave Patterns

Lambisia AW. et al, (2026), Open Forum Infectious Diseases, 13

Modelling catastrophic extinction in stochastic birth-death process: Analytical insights, estimation, and efficient simulation

Twumasi C., (2026), Computational Statistics & Data Analysis, 215, 108302 - 108302

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial

Liatsikos K. et al, (2026), The Lancet Microbe, 7, 101267 - 101267

Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B

Kalafateli M. et al, (2026), Clinical Gastroenterology and Hepatology, 24, 701 - 712.e8

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies

Cheliotis KS. et al, (2026), Vaccine, 75, 128280 - 128280

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Turan G. et al, (2026), Vaccines, 14

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Alam N. et al, (2026), EMBO molecular medicine

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), The Lancet. Infectious diseases

The age-specific concentrations and seroprevalence of antibodies against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) across three sites in Kenya.

Muthumbi EM. et al, (2026), The Journal of infectious diseases

Protocol for precision cutting and short-term culture of lymph node tissue slices for modeling of innate immune responses ex vivo.

Fergusson JR. et al, (2026), STAR protocols, 7

Context-specific regulatory genetic variation in MTOR dampens neutrophil-T cell crosstalk in pneumonia-associated sepsis

Zhang P. et al, (2026), Nature Communications

Lipid‐Facilitated Opening of the ADAM10 Sheddase Revealed by Enhanced Sampling Simulations

Schahl A. et al, (2026), Advanced Science

Vaccines and antimicrobial resistance: from science to policy—summary and outcomes

MacLennan CA. et al, (2026), Philosophical Transactions B, 381

Vaccines and antimicrobial resistance: from science to policy—introduction

MacLennan CA. and Davies S., (2026), Philosophical Transactions B, 381

Lessons from COVID-19: the 100 Days Mission and antimicrobial resistance

Hatchett R. and MacLennan CA., (2026), Philosophical Transactions B, 381

Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections

Hagedoorn N. et al, (2026)

Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope

Zheng-Gérard C. et al, (2026), EMBO Reports, 27, 1580 - 1606

Cookies on this website

Search results

Showing results for